Chemotherapy compliance of patients with digestive system cancer and its influencing factors

Abstract

Abstract:

AIM: To investigate the relationship between the chemotherapy compliance and general status, symptoms of chemotherapy, emotional experience and resilience of patients with digestive system cancer. METHODS: The Connor-Davidson Resilience Scale (CD-RISC), MD Anderson Symptom Inventory (MDASI) and chemotherapy compliance questionnaire were used to assess the 165 digestive system cancer patients. RESULTS:The score of chemotherapy compliance was (15±7) points, which was influenced by such factors as age of patients, mode of payment and participation in exercise (P<0.05). Score of chemotherapy compliance was significantly positively correlated with score of MDASI (r＝0.812), while significantly negatively correlated with CD-RISC (r＝-0.177). The scores of CD-RISC and MDASI as well as two factors of MDASI were applied to the multiple regression equation. CONCLUSION:Patient's symptoms during chemotherapy, emotional experience and resilience are important factors influencing chemotherapy compliance. Medical staff and relevant departments are required to take effective measures to improve the chemotherapy compliance of patients.

Key words: digestive system cancer, chemotherapy compliance, resilience, MD Anderson Symptom

CLC Number:

R730.51

LI Xiu, JI Zhaoning. Chemotherapy compliance of patients with digestive system cancer and its influencing factors[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 565-569.

References

［1］郝婕，陈万青．2012中国肿瘤登记年报［M］.北京：军事医学科学出版社，2012:16.
［2］房丽，马守东，王红阳，等．肿瘤患者化疗依从性相关影响因素Logistic 回归分析［J］.中国医药导报，2014，11(3):61-63．
［3］林明生，王常松．中医药对胃癌术后化疗患者的辨治思路［J］．长春中医药大学学报，2015，32(2):278-280．
［4］马海利．情志护理对消化道肿瘤化疗患者情绪及生活质量的影响［J］.中医药导报，2014，20(5):142-144．
［5］Connor KM，Davidson JRT. Development of a new resilience scale：the Connor-Davidson Resilience Scale（CD-RISC）［J］. Depress Anxiety，2003，18（2）：76-82.
［6］Cleeland CS，Mendoza TR，Wang XS，et al. Assessing symptom distress in cancer: The MD Anderson symptom inventory［J］.Cancer 2000, 89（7）：1634-1646.
［7］孙静，韩文志，柳燕．抗肿瘤药物的不良反应及防治措施［J］. 长春中医药大学学报，2010，26(5): 767-768．
［8］马婷婷，王会英，强万敏．肿瘤患者口服化疗药物依从性影响因素的Logistic回归分析［J］.护士进修杂志，2015，30(21):1927-1930．
［9］荆秋芳，于丽，岳辰．恶性肿瘤患者化疗依从性的影响因素及干预效果分析［J］. 中国医院用药评价与分析，2010，10(3):275-276．
［10］Ingersoll KS，Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature［J］.J Behave Med，2008，31（3）：213 -224.
［11］Stewart DE, Yuen T. A systematic review of resilience in the physically ill ［J］.Psychosomatic,2011,52(3)：199-209.
［12］White B，Drive S，Warren AM. Resilience and indicators of adjustment during rehabilitation from a spinal cord injury ［J］. Rehabi Psychol，2010，55（1）：23-32.
［13］王军霞．消化系统癌症患者心理困扰影响因素及干预效果研究［D］合肥：安徽医科大学，2014.
［14］Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study ［J］. Psychooncology, 2002, 11(2): 142-153.
［15］马伟娜，桑标，洪灵敏．心理弹性及其作用机制的研究述评［J］．华东师范大学学报（教育科学版），2008, 26（1）：89-95．
［16］钱南萍，魏润新，许静，等．临床药师对肿瘤化疗患者的用药教育［J］．中国药房，2012,23（10）：951-953．

[1]	LIN Zhong, XIE Qunli, LI Shengying, JIN Hui, XU Fenfen, XIE Liyun, JIANG Zhengli. Advanced of HER-2/neu epitope anti-tumor vaccine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1046-1052.
[2]	WANG Dong-yan, LI Xin, ZHANG Hong-quan. Immune protecting on tumor-bearing mouse of C21 sterols in Baishouwu [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(2): 168-172.
[3]	SHEN Su-jian, WU Jin-ming, JIN Si-si, HUANG Zhi-ming, WU Jian-sheng. Antitumoral effect of the immunoconjugate composed of ricin A-chain and EGFR mab [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1234-1238.